FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to obstetrics and gynecology and can be used for correction of endothelial dysfunction in pregnant women with iron deficiency anemia in the second trimester of gestation. Medication "Ferretab" is administered to patients in dose 1 dragee per day per os during 3 weeks.
EFFECT: method possesses high efficiency and provides possibility of timely correction of endothelial dysfunction in case of iron deficiency anemia in order to prevent possible complications of pregnancy and early neonatal period due to elimination of tissue hypoxia and normalisation of iron level in organism.
4 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING IRON DEFICIENCY ANEMIA IN PREGNANT WOMEN OF DIFFERENT SOMATOTYPES | 2019 |
|
RU2723359C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVOURABLE MATERNAL OUTCOMES DURING PREGNANCY, CHILDBIRTH AND THE POSTPARTUM PERIOD | 2023 |
|
RU2803129C1 |
| METHOD OF PREVENTION OF IRON-DEFENSE ANEMIA OF UNDERAGED PREGNANT WOMEN | 2016 |
|
RU2616264C1 |
| METHOD FOR PREDICTING THE RECURRENCE OF EARLY PREECLAMPSIA BY MARKERS OF ENDOTHELIAL DYSFUNCTION | 2022 |
|
RU2795090C1 |
| METHOD FOR FETOPLACENTAL INSUFFICIENCY PREVENTION FOR PREGNANT WOMEN WITH CHRONIC KIDNEY DISEASE | 2016 |
|
RU2623064C1 |
| METHOD OF CREATING A PERSONALIZED PROGRAM OF PREGRAVIDARY PREPARATION OF PATIENTS WITH INFERTILITY AND OBESITY FOR AUXILIARY REPRODUCTIVE TECHNOLOGIES | 2022 |
|
RU2796893C1 |
| METHOD FOR PREDICTING ANEMIA IN PREGNANT WOMEN WITH COVID-19 PNEUMONIA | 2022 |
|
RU2772906C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF CRITICAL CONDITIONS OF WOMEN DURING CHILDBEARING AND DURING THE PUERPERIUM | 2017 |
|
RU2647459C1 |
| METHOD OF TREATING ANAEMIA IN PREGNANT WOMEN | 2010 |
|
RU2445966C1 |
| METHOD FOR TREATING ANEMIA DURING PREGNANCY | 2006 |
|
RU2319489C2 |
